The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in Ireland is a research paper published in Journal of Clinical Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Wellcome Trust and the Health Research Board
Grant: 203930/B/16/Z
Wellcome Trust and the Health Research Board
Grant: DK095424 (JAH)
Wellcome Trust and the Health Research Board
Grant: DK62294 (JAH)
Wellcome Trust and the Health Research Board
Grant: DK089206 (JAH)
Wellcome Trust and the Health Research Board
Grant: DK101442 (JAH)
NIDDK NIH HHS
Grant: R56 DK089206
NIDDK NIH HHS
Grant: R01 DK101442
NIDDK NIH HHS
Grant: R01 DK118528
Health Research Board
Grant: CTN-2021-006
NIH HHS
Grant: DK095424, DK62294, DK089206, DK101442
Wellcome Trust
Grant: unidentified
unidentified
Wellcome Trust
Grant: 203930
Wellcome – Health Research Board Irish Clinical Academic Training Programme
National Institutes of Health
Grant: 1R56DK089206-01
Glycated CD59 as a Biomarker for Diabetes
National Institutes of Health
Grant: 5R01DK101442-05
Human Studies on Blood Levels of Glycated CD59 as a Biomarker in Diabetes
Wellcome Trust
Wellcome Trust
FWCI
1.41
Citation Percentile
0.8%
Influential Citations
1
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals